title: Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections.
abstract: Candida albicans and, more recently, non-C. albicans Candida spp. are considered the most frequent fungi in hospitals. This study analyzed Candida spp. isolates and compared the frequency of different species, that is, C. albicans and non-C. albicans Candida spp., and the origins of isolates, that is, from hospital environments or infections. Yeast virulence factors were evaluated based on biofilm production and metabolic activity. Hemolysin production and the antifungal susceptibility profiles of isolates were also evaluated. Candida spp. were highly prevalent in samples collected from hospital environments, which may provide a reservoir for continuous infections with these yeasts. There were no differences in the biofilm productivity levels and metabolic activities of the environmental and clinical isolates, although the metabolic activities of non-C. albicans Candida spp. biofilms were greater than those of the C. albicans biofilms (p < 0.05). Clinical samples had higher hemolysin production (p < 0.05) and lower susceptibility to fluconazole (p < 0.05). Non-C. albicans Candida spp. predominated in samples collected from hospital environments and infections (p < 0.05). These species had a lower susceptibility to fluconazole and amphotericin B, and their biofilms had higher metabolic activities than those produced by C. albicans, which may explain the increased incidence of fungal infections with these yeasts during recent years.
authors.affiliation: Microbiology and Immunology Department, Biomedical Sciences Institute, Federal University of Alfenas (UNIFAL-MG), Alfenas, MG, Brazil.
authors.forename: A V
authors.initials: AV
authors.lastname: Ferreira
authors.forename: C G
authors.initials: CG
authors.lastname: Prado
authors.forename: R R
authors.initials: RR
authors.lastname: Carvalho
authors.forename: K S T
authors.initials: KS
authors.lastname: Dias
authors.forename: A L T
authors.initials: AL
authors.lastname: Dias
mesh_terms: D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D018441:Biofilms / Q000254:growth & development; D002175:Candida / Q000302:isolation & purification* / Q000378:metabolism / Q000472:pathogenicity / Q000502:physiology*; D002177:Candidiasis / Q000382:microbiology*; D004783:Environmental Microbiology; D015725:Fluconazole / Q000494:pharmacology; D006460:Hemolysin Proteins / Q000378:metabolism; D006761:Hospitals; D006801:Humans; D008826:Microbial Sensitivity Tests; D015995:Prevalence
chemical_list: D000935:Antifungal Agents; D006460:Hemolysin Proteins; D000666:Amphotericin B; D015725:Fluconazole